Kathleen Ford - 02 Jan 2026 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role: Chief Operating Officer
Signature: Teresa Bair, Attorney-in-fact for Kathleen Ford
Issuer symbol: KURA
Transactions as of: 02 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Jan 2026, 16:30:12 UTC
Previous filing: 14 Nov 2025
Next filing: 27 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
FORD KATHLEEN	Chief Operating Officer	C/O KURA ONCOLOGY, INC., 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO	Teresa Bair, Attorney-in-fact for Kathleen Ford	06 Jan 2026	0001785406

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KURA	Common Stock	Award	$0	+50,000	+47%	$0.000000	155,373	02 Jan 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KURA	Option to purchase common stock	Award	$0	+100,000		$0.000000	100,000	02 Jan 2026	Common Stock	100,000	$10.34	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30.
F2	This option vests in 48 equal monthly installments commencing on the grant date.